Trial intelligence / Profile preview

Total glucosides of paeony for mild autoimmune hepatitis

ChiCTR-IIR-17011926Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jul 2017
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of total glucosides of paeony in autoimmune hepatitis (AIH) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Complete remission rate. Started Jul 2017; status: recruiting.

02

Drugs

total glucosides of paeony
03

Conditions

autoimmune hepatitis (AIH)

Beyond the preview

Go deeper on ChiCTR-IIR-17011926.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17011926.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call